Showing results (1-10 of 365) with videos related to
Sort By:
Pageof 37
Immunopharmacology|September 21, 2000
Interleukin 2 maintains biologic stability and sterility over prolonged timeM Safar, R P JunghansCancer Immunology, Immunotherapy : CII|January 1, 1990
A strategy for evaluating lymphokine activation and novel monoclonal antibodies in antibody-dependent cell-mediated cytotoxicity and effector cell retargeting assaysR P JunghansEnvironmental Research|June 1, 1983
A review of the toxicity of methylmercury compounds with application to occupational exposures associated with laboratory usesR P JunghansEuropean Journal of Human Genetics : EJHG|January 29, 2009
Dystrophia myotonia: why focus on foci?R P JunghansAnalytical Biochemistry|August 15, 1996
Optimization of radioligand binding and radioimmuno assaysR P JunghansImmunologic Research|February 1, 1997
Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgGR P JunghansImmunology|July 11, 2000
The role of the Brambell receptor (FcRB) in liver: protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bileP Telleman, R P JunghansProceedings of the National Academy of Sciences of the United States of America|May 28, 1996
The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptorR P Junghans, C L AndersonJournal of Immunological Methods|November 27, 1998
Measurement and biological correlates of antibody bioactivity during antibody immunotherapiesD S Hagg, R P JunghansThe Journal of Experimental Medicine|April 1, 1996
Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody bindingR P Junghans, T A WaldmannPageof 37